EVOL

Fair Value

Price (monthly) Typical-P/S value line (dashed = revenue estimates) above fair value below fair value
Undervalued
-82%
vs fair value
Price
$0.6
Fair value
$3.28
Typical P/S, 20y
1.9x
Revenue/share growth rate
-0.7%
Trailing 12M revenue/share

Results are highly cyclical for EVOL, so multiple-based fair value is less reliable here.

FY2002200320042007200820092010201120122013201420152016201720182019202020212022E2023E
High6.145.247.498.358.287.7211.1911.389.985.925.705.801.432.483.94
Low2.401.561.696.026.065.225.577.785.303.854.051.110.710.601.74
Rev/Sh2.133.162.423.723.803.923.792.382.142.212.462.232.172.162.712.142.142.231.87E1.75E
Chg/Yr+48%-24%+54%+2%+3%-3%-37%-10%+3%+11%-9%-3%-0%+26%-21%+0%+5%-16%-7%
Div0.000.000.000.000.000.000.150.154.000.360.420.440.220.000.000.000.000.00
How these numbers are calculated

Fair value (1.9x sales) multiplies each year's revenue per share by the price-to-sales ratio investors have typically paid for EVOL — the median of the last 20 fiscal years' average price over that year's revenue per share. The line extends forward with analyst revenue estimates (dashed).

Revenue comes from reported quarters; share counts come from market value divided by the share price, so buybacks and splits are handled correctly. The verdict calls a stock over- or undervalued only when the price sits more than 10% from the line. Analyst estimates for this listing are published in its home currency; they are converted to the reported basis using the historical relationship between the two.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.